Markers of anaphylaxis – a systematic review

Johansson, 2001, A revised nomenclature for allergy: AN EAACI position statement form the EAACI nomenclature task force, Allergy, 56, 813, 10.1034/j.1398-9995.2001.t01-1-00001.x Kruszewski, 2009 Joint Task Force on Practice Parameters, 2005, The diagnosis and management of anaphylaxis: an updated practice parameter, J Allergy Clin Immunol, 115, S483 LoVerde, 2017, Contemporary reviews in critical care medicine: anaphylaxis, Chest Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 21, e1000097, 10.1371/journal.pmed.1000097 Krishnaswamy, 2001, The human mast cell: functions in physiology and disease, Adv Front Biosci, 6, 1109, 10.2741/krishnas Kounis, 2016, Kounis syndrome: an update on epidemiology, pathogenesis, diagnosis and therapeutic management, Clin Chem Lab Med, 54, 1545, 10.1515/cclm-2016-0010 Lieberman, 2016, Mast cells and anaphylaxis, Adv Curr Allergy Asthma Rep, 16, 20, 10.1007/s11882-016-0598-5 Stasikowska-Kanicka, 2012, Mast cells and eosinophils are involved in activation of ulcerative colitis, Adv Med Sci, 57, 230, 10.2478/v10039-012-0029-3 Sala-Cunill, 2015, Markers of anaphylaxis, beyond tryptase, Curr Opin Allergy Clin Immunol, 15, 329, 10.1097/ACI.0000000000000184 Nassiri, 2016, Serum levels of 9α, 11β-PGF2 and cysteinyl leukotrienes are useful biomarkers of anaphylaxis, J Allergy Clin Immunol, 137, 312, 10.1016/j.jaci.2015.07.001 Simons, 2015, 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines, World Allergy Organ J, 8, 32, 10.1186/s40413-015-0080-1 Brown, 2013, Anaphylaxis: clinical patterns, mediator release, and severity, J Allergy Clin Immunol, 132, 1141, 10.1016/j.jaci.2013.06.015 Stobiecki, 2007, Tryptaza w diagnostyce chorób alergicznych, Alergol Immunol, 4, 25 Finkelman, 2016, Human IgE-independent systemic anaphylaxis, J Allergy Clin Immunol, 137, 1674, 10.1016/j.jaci.2016.02.015 Sala-Cunill, 2015, Plasma contact system activation drives anaphylaxis in severe mast cell-mediated allergic reactions, J Allergy Clin Immunol, 35, 1031, 10.1016/j.jaci.2014.07.057 Nowak, 2015, [Anaphylactic reactions to low-molecular weight chemicals]: Reakcje anafilaktyczne na substancje chemiczne o małej masie cząsteczkowej, Postepy Hig Med Dosw (Online), 69, 197 Ben-Shoshan, 2011, Anaphylaxis: past, present and future, Allergy, 66, 1, 10.1111/j.1398-9995.2010.02422.x Marone, 1995, Human basophils and mast cells: biological aspects. Dvorak AM ultrastructural analysis of human mast cells and basophils, Chem Immunol, 61, 1 Marone, 1995, Human basophils and mast cells: biological aspects: MacGlashan DW-signal transduction and cytokine production by human basophils, Chem Immunol Basel Karger, 61, 88 Trivedi, 2009, Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations, J Allergy Clin Immunol, 124, 1099, 10.1016/j.jaci.2009.07.026 Michalska-Krzanowska, 2012, Tryptase in diagnosing adverse suspected anaphylactic reaction, Adv Clin Exp Med, 21, 403 Xiang, 2011, Usefulness of serum tryptase level as an independent biomarker for coronary plaque instability in a Chinese population, Atherosclerosis, 215, 494, 10.1016/j.atherosclerosis.2011.01.006 Pastorello, 2014, Serum tryptase: a new biomarker in patients with acute coronary syndrome?, Int Arch Allergy Immunol, 164, 97, 10.1159/000360164 Pastorello, 2015, Serum tryptase detected during acute coronary syndrome is significantly related to the development of major adverse cardiovascular events after 2 years, Clin Mol Allergy, 13, 14, 10.1186/s12948-015-0013-0 Bot, 2015, Mast cells as effectors in atherosclerosis, Arterioscler Thromb Vasc Biol, 35, 265, 10.1161/ATVBAHA.114.303570 Petra, 2014, Spectrum of mast cell activation disorders, Expert Rev Clin Immunol, 10, 729, 10.1586/1744666X.2014.906302 Kounis, 2013, Coronary hypersensitivity disorder: the Kounis syndrome, Clin Ther, 35, 563, 10.1016/j.clinthera.2013.02.022 Correale, 2008, Acute phase proteins in atherosclerosis (acute coronary syndrome), Cardiovasc Hematol Agents Med Chem, 6, 272, 10.2174/187152508785909537 Kaartinen, 1994, Mast cells of two types differing in neutral protease composition in the human aortic intima Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas, Arterioscler Thromb, 14, 966, 10.1161/01.ATV.14.6.966 Baram, 2001, Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha, J Immunol, 167, 4008, 10.4049/jimmunol.167.7.4008 Johnson, 1998, Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques, Arterioscler Thromb Vasc Biol, 18, 1707, 10.1161/01.ATV.18.11.1707 Lindstedt, 2007, Mast cells in vulnerable atherosclerotic plaques, a view to a kill, J Cell Mol Med, 11, 739, 10.1111/j.1582-4934.2007.00052.x He, 2013, Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases, Curr Pharm Des, 19, 1114, 10.2174/1381612811319060012 Kounis, 2011, Anaphylaxis-induced hyperfibrinogenolysis and the risk of Kounis syndrome: the dual action of tryptase, Am J Emerg Med, 29, 1229, 10.1016/j.ajem.2011.06.002 Yeong, 2011, Tryptase promotes human monocyte-derived macrophage foam cell formation by suppressing LXRά activation, Mol Cell Biol Lipids, 1801, 567, 10.1016/j.bbalip.2010.01.011 Kounis, 2011, Tryptase levels in coronary syndromes and in hypersensitivity episodes: a common pathways towards Kounis syndrome, Atherosclerosis, 219, 28, 10.1016/j.atherosclerosis.2011.07.101 Comment, 2014, Measurement of β-tryptase in postmortem serum, pericardial fluid, urine and vitreous humor in the forensic setting, Forensic Sci Int, 240, 29, 10.1016/j.forsciint.2014.04.006 Schwartz, 1989, Time course of appearance and disapperance of human mast cell tryptase in the circulation after anaphylaxis, J Clin Invest, 83, 1551, 10.1172/JCI114051 Austin, 2001, Allergies, anaphylaxis and systemic mastocytosis, 1919 Swerdlow, 2008, Mastocytosis (mast cell disease), Vol 2, 54 Fisher, 1994, Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention, Eur J Anaestesiol, 11, 263 Yunginger, 1991, Laboratory investigation of deaths due to anahylaxis, J Forensic Sci, 36, 857, 10.1520/JFS13095J Haeberli, 2003, Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy, Clin Exp Allergy, 33, 1216, 10.1046/j.1365-2222.2003.01755.x Kucharewicz, 2007, Basal serum tryptase level correlates with severity of hymenoptera sting and age, J Invest Allergol Clin Immunol, 17, 65 Ruëff, 2010, European Academy of Allergy and Clinical Immunology Interest Group: predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase, J Allergy Clin Immunol, 126, 105, 10.1016/j.jaci.2010.04.025 McLean-Tooke, 2014, Postmortem serum tryptase levels in anaphylactic and non-anaphylactic deaths, J Clin Pathol, 67, 134, 10.1136/jclinpath-2013-201769 Buckley, 2001, Elevated serum concentrations of beta-tryptase, but not alpha-tryptase, in Sudden Infant Death Syndrome (SIDS). An investigation of anaphylactic mechanisms, Clin Exp Allergy, 31, 1696, 10.1046/j.1365-2222.2001.01213.x Ruëff, 2011, Release of mast cell tryptase into saliva: a tool to diagnose food allergy by a mucosal challenge test?, Int Arch Allergy Immunol, 155, 282, 10.1159/000320492 Prieto-García, 2014, Mast cell-restricted tetramer-forming tryptases and their beneficial roles in hemostasis and blood coagulation, Immunol Allergy Clin North Am, 34, 263, 10.1016/j.iac.2014.01.001 Srivastava, 2014, J Clin Pathol, 67, 614, 10.1136/jclinpath-2013-202005 Caughey, 2016, Mast cell proteases as pharmacological targets, Eur J Pharmacol, 778, 44, 10.1016/j.ejphar.2015.04.045 Jutel, 2009, Histamine, histamine receptors and their role in immune pathology, Clin Exp Allergy, 39, 1786, 10.1111/j.1365-2222.2009.03374.x Jones, 2011, Histamine: new thoughts about a familiar mediator, Clin Pharmacol Ther, 89, 189, 10.1038/clpt.2010.256 Kurek, 2011, Anafilaksja, 483 Simons, 2011, Histamine and H1-antihistamines: celebrating a century of progress, J Allergy Clin Immunol, 128, 1139, 10.1016/j.jaci.2011.09.005 Leurs, 1995, Molecular pharmacological aspects of histamine receptors, Pharmacol Ther, 66, 413, 10.1016/0163-7258(95)00006-3 Togias, 2003, H1-receptors: localization and role in airway physiology and in immune functions, J Allergy Clin Immunol, 112, S60, 10.1016/S0091-6749(03)01878-5 Smit, 1999, Molecular properties and signalling pathways of the histamine H1 receptor, Clin Exp Allergy, 29, 19, 10.1046/j.1365-2222.1999.00007.x-i1 Simons, 2004, Advances in H1-antihistamines, N Engl J Med, 351, 2203, 10.1056/NEJMra033121 Simons, 2009, Histamine and H1-antihistamines, 1517 Haas, 2008, Histamine in the nervous system, Physiol Rev, 88, 1183, 10.1152/physrev.00043.2007 Thakkar, 2011, Histamine in the regulation of wakefulness, Sleep Med Rev, 15, 65, 10.1016/j.smrv.2010.06.004 Leurs, 2011, En route to new blockbuster antihistamines: surveying the offspring of the expanding histamine receptor family, Trends Pharmacol Sci, 32, 250, 10.1016/j.tips.2011.02.004 Lichtenstein, 1975, The effects of the H1 and H2 antihistamines on allergic histamine release and its inhibition by histamine, J Pharmacol Exp Ther, 192, 441 Jutel, 2002, Immune regulation by histamine, Curr Opin Immunol, 14, 735, 10.1016/S0952-7915(02)00395-3 Kuhne, 2011, Several down, a few to go: histamine H3 receptor ligands making the final push towards the market?, Expert Opin Invest Drugs, 20, 1629, 10.1517/13543784.2011.625010 Singh, 2013, Histamine H3 receptor function and ligands: recent developments, Mini Rev Med Chem, 13, 47, 10.2174/138955713804484695 Lovenberg, 1999, Cloning and functional expression of the human histamine H3 receptor, Mol Pharmacol, 55, 1101, 10.1124/mol.55.6.1101 Haas, 2008, Histamine in the nervous system, Physiol Rev, 88, 1183, 10.1152/physrev.00043.2007 Chrusch, 1999, Histamine H3 receptor blockade improves cardiac function in canine anaphylaxis, Am J Respir Crit Care Med, 160, 1142, 10.1164/ajrccm.160.4.9901021 Endou, 1994, Histamine H3 receptor signaling in the heart: possible involvement of Gi/Go proteins and N-Type Ca channels, J Pharmacol Exp Ther, 269, 221 McLeod, 1993, Production by R-alpha-methylhistamine of a histamine H3 receptor mediated decrease in basal vascular resistance in guinea-pigs, Br J Pharmacol, 110, 553, 10.1111/j.1476-5381.1993.tb13846.x Levi, 2000, Histamine H(3)-receptors: a new frontier in myocardial ischemia, J Pharmacol Exp Ther, 292, 825 Tiligada, 2009, Histamine H3 and H4 receptors as novel drug targets, Expert Opin Invest Drugs, 18, 1519, 10.1517/14728220903188438 Liu, 2014, Histamine H4 receptor antagonists for the treatment of inflammatory disorders, Drug Discov Today, 19, 1222, 10.1016/j.drudis.2014.05.007 Capelo, 2016, Cellular analysis of the histamine H4 receptor in human myeloid cells, Biochem Pharmacol, 103, 74, 10.1016/j.bcp.2016.01.007 Deiteren, 2015, Histamine H4 receptors in the gastrointestinal tract, Br J Pharmacol, 172, 1165, 10.1111/bph.12989 Wang, 2016, Combined blockade of the histamine H1 and H4 receptor suppresses peanut-induced intestinal anaphylaxis by regulating dendritic cell function, Allergy, 71, 1561, 10.1111/all.12904 Reber, 2017, The pathophysiology of anaphylaxis, J Allergy Clin Immunol, 140, 335, 10.1016/j.jaci.2017.06.003 Weiss, 1982, Bronchoconstrictor effects of leukotriene C in humans, Science, 216, 196, 10.1126/science.7063880 Weiss, 1983, Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy, JAMA, 249, 2814, 10.1001/jama.1983.03330440052033 Kaliner, 1981, Effects of infused histamine: analysis of the effects of H-1 and H-2 histamine receptor antagonists on cardiovascular and pulmonary responses, J Allergy Clin Immunol, 68, 365, 10.1016/0091-6749(81)90134-2 Vigorito, 1983, Cardiovascular effects of histamine infusion in man, J Cardiovasc Pharmacol, 5, 531, 10.1097/00005344-198307000-00004 Lieberman, 2015, Anaphylaxis − a practice parameter update 2015, Ann Allergy Asthma Immunol, 115, 341, 10.1016/j.anai.2015.07.019 Lin, 2000, Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study, J Allergy Clin Immunol, 106, 65, 10.1067/mai.2000.107600 Marone, 2014, Human heart as a shock organ in anaphylaxis, Allergo J Int, 23, 60, 10.1007/s40629-014-0007-3 Vigorito, 1986, Effect of activation of the H1 receptor on coronary hemodynamics in man, Circulation, 73, 1175, 10.1161/01.CIR.73.6.1175 Vigorito, 1987, Effects of histamine on coronary hemodynamics in man: role of H1 and H2 receptors, J Am Coll Cardiol, 10, 1207, 10.1016/S0735-1097(87)80120-1 Patterson, 1999, Latex anaphylaxis causing heart block: role of ranitidine, Can J Anaesth, 46, 776, 10.1007/BF03013914 Imamura, 1995, Functional identification of histamine H3-receptors in the human heart, Circ Res, 77, 206, 10.1161/01.RES.77.1.206 Imamura, 1996, Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release during protracted myocardial ischemia. Comparison with adenosine A1 receptors and 2-adrenoceptors, Circ Res, 78, 475, 10.1161/01.RES.78.3.475 Silver, 2002, Decreased intracellular calcium mediates the histamine H3-receptor-induced attenuation of norepinephrine exocytosis from cardiac sympathetic nerve endings, Proc Natl Acad Sci U S A, 99, 501, 10.1073/pnas.012506099 Theoharides, 2006, The critical role of mast cells in allergy and inflammation, Ann N Y Acad Sci, 1088, 78, 10.1196/annals.1366.025 Tsigkas, 2011, Allergic reaction reveals a non-lethal late stent thrombosis. A new subtype of Kounis syndrome?, Int J Cardiol, 149, 281, 10.1016/j.ijcard.2011.02.060 Braquet, 1987, Platelet-activating factor and cellular immune response, Immunol Today, 8, 345, 10.1016/0167-5699(87)90010-7 Camussi, 1990, The role of platelet activating factor in inflammation, Clin Immun Immunopathol, 57, 331, 10.1016/0090-1229(90)90108-3 Chao, 1993, Platelet-activating factor: receptor and signal transduction, Biochem J, 292, 617, 10.1042/bj2920617 Hanahan, 1986, Platelet-activating factor: a biologically active phosphoglyceride, Annu Rev Biochem, 55, 483, 10.1146/annurev.bi.55.070186.002411 McManus, 1993, Biology of disease: PAF molecular heterogeneity: pathobiological implications, Lab Invest, 69, 639 Prescott, 1990, Platelet-activating factor, J Biol Chem, 265, 17381, 10.1016/S0021-9258(18)38167-5 Snyder, 1990, Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators, Am J Physiol Cell Physiol, 259, C697, 10.1152/ajpcell.1990.259.5.C697 Vargaftig, 1989, Platelet activating factor: biology receptors and antagonists, Handb Inflamm, 6, 113 Venable, 1993, Platelet-activating factor: a phospholipid autacoid with diverse actions, J Lipid Res, 34, 691, 10.1016/S0022-2275(20)39691-7 Benveniste, 1972, Leukocyte-dependent histamine release from rabbit platelets The role of IgE, basophils, and platelet-activating factor, J Exp Med, 136, 1356, 10.1084/jem.136.6.1356 Farr, 1980, Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF), Clin Immunol Immunopathol, 15, 318, 10.1016/0090-1229(80)90044-6 Stafforini, 1991, Platelet-activating factor acetylhydrolase in human tissue and blood cells, Lipids, 26, 979, 10.1007/BF02536488 Tselepis, 1995, PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme, Arterioscler Thromb Vasc Biol, 15, 1764, 10.1161/01.ATV.15.10.1764 Hattori, 1995, Cloning and expression of cDNA encoding the beta-subunit (30-kDa subunit) of bovine brain platelet-activating factor acetylhydrolase, J Biol Chem, 270, 31345, 10.1074/jbc.270.52.31345 Hattori, 1996, cDNA cloning and expression of intracellular platelet-activating factor (PAF) acetylhydrolase II. Its homology with plasma PAF acetylhydrolase, J Biol Chem, 271, 33032, 10.1074/jbc.271.51.33032 Hattori, 1993, Purification and characterization of bovine brain platelet-activating factor acetylhydrolase, J Biol Chem, 268, 18748, 10.1016/S0021-9258(17)46693-2 Smiley, 1991, Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor, J Biol Chem, 266, 11104, 10.1016/S0021-9258(18)99133-7 Heery, 1995, Oxidatively modified LDL contains phospholipids with platelet activating factor-like activity and stimulates the growth of smooth muscle cells, J Clin Invest, 96, 2322, 10.1172/JCI118288 Gill, 2015, Platelets in the immune response: revisiting platelet-activating factor in anaphylaxis, Adv J Allergy Clin Immunol, 135, 1424, 10.1016/j.jaci.2015.04.019 Montrucchio, 2000, Role of platelet-activating factor in cardiovascular pathophysiology, Physiol Rev, 80, 1669, 10.1152/physrev.2000.80.4.1669 Shirazaki, 2005, Expression and localization of platelet-activating factor receptor in human nasal mucosa, Ann Allergy Asthma Immunol, 95, 190, 10.1016/S1081-1206(10)61210-0 Braquet, 1989, Is there a case for PAF antagonists in the treatment of ischemic states?, Trends Pharmacol Sci, 10, 23, 10.1016/0165-6147(89)90103-X Bratton, 1989, Cellular origin of PAF, 23 Lotner, 1980, Human neutrophil-derived platelet activating factor, J Immunol, 124, 676, 10.4049/jimmunol.124.2.676 Triggiani, 1991, Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells, J Immunol, 147, 660, 10.4049/jimmunol.147.2.660 Camussi, 1983, The release of platelet activating factor from human endothelial cells in culture, J Immunol, 131, 2397, 10.4049/jimmunol.131.5.2397 McIntyre, 1986, Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet activating factor and bind neutrophils, Proc Natl Acad Sci U S A, 83, 2204, 10.1073/pnas.83.7.2204 McIntyre, 1985, Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate, J Clin Invest, 76, 271, 10.1172/JCI111957 Camussi, 1988, Synthesis and release of platelet-activating factor is inhibited by plasma alpha-1-proteinase inhibitor or alpha-1-antichymotrypsin and is stimulated by proteinases, J Exp Med, 168, 1293, 10.1084/jem.168.4.1293 Lewis, 1988, Hydrogen peroxide stimulates the synthesis of platelet activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion, J Clin Invest, 82, 2045, 10.1172/JCI113825 Montrucchio, 1993, Role of platelet-activating factor in hypotension and platelet activation induced by infusion of thrombolytic agents in rabbits, Circ Res, 72, 658, 10.1161/01.RES.72.3.658 Montrucchio, 1996, Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor and P-Selectin, Circulation, 93, 2152, 10.1161/01.CIR.93.12.2152 Au, 1994, Zymosan-induced IL-8 release from human neutrophils involves activation via the CD11b/CD18 receptor and endogenous platelet activating factor as an autocrine modulator, J Immunol, 152, 5411, 10.4049/jimmunol.152.11.5411 Bussolino, 1995, Involvement of a serine protease in the synthesis of platelet activating factor by endothelial cells stimulated by IL-1a or TNF-alpha, Eur J Immunol, 24, 3131, 10.1002/eji.1830241233 Bussolino, 1988, Synthesis and release of platelet activating factor by human vascular endothelial cells treated with tumor necrosis factor and interleukin-1 alpha, J Biol Chem, 263, 11856, 10.1016/S0021-9258(18)37865-7 Janero, 1990, Production and release of platelet activating factor by the injured heart-muscle cell (cardiomyocyte), Res Commun Chem Pathol Pharmacol, 67, 201 Honda, 1991, Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung, Nature, 349, 342, 10.1038/349342a0 Ishii, 1998, Impaired anaphylactic responses with intact sensitivity to endotoxin in mice lacking a platelet-activating factor receptor, J Exp Med, 187, 1779, 10.1084/jem.187.11.1779 Kunz, 1992, The human leukocyte platelet activating factor receptor, J Biol Chem, 267, 9101, 10.1016/S0021-9258(19)50394-5 Sugimoto, 1992, Molecular cloning and characterization of the platelet activating factor receptor gene expressed in the human heart, Biochem Biophys Res Commun, 189, 617, 10.1016/0006-291X(92)92245-S Ye, 1991, Characterization of a human cDNA that encodes a functional receptor for platelet activating factor, Biochem Biophys Res Commun, 180, 105, 10.1016/S0006-291X(05)81261-6 Bratton, 1992, The mechanism of internalization of platelet activating factor in activated human neutrophils: enhanced transbilayer movement across the plasma membrane, J Immunol, 148, 514, 10.4049/jimmunol.148.2.514 Zimmerman, 1992, Endothelial cell interactions with granulocytes: tethering and signaling molecules, Immunol Today, 13, 93, 10.1016/0167-5699(92)90149-2 Bussolino, 1987, Endothelial cells are targets for platelet activating factor: platelet activating factor induces changes in cytoskeleton structure, J Immunol, 139, 2439, 10.4049/jimmunol.139.7.2439 Benveniste, 1983, The actions of PAF-acether (platelet-activating factor) on guinea-pig isolated heart preparations, Br J Pharmacol, 80, 81, 10.1111/j.1476-5381.1983.tb11052.x Findlay, 1981, The contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine, Am J Physiol Cell Physiol, 241, C130, 10.1152/ajpcell.1981.241.3.C130 Kester, 1984, The potentiation of arterial contraction with platelet activating factor, Pflugers Arch, 400, 200, 10.1007/BF00585041 Stahl, 1987, Heterogeneity of vascular smooth muscle responsiveness to lipid vasoactive mediators, Blood Vessels, 24, 24 Montrucchio, 1986, In vitro contractile effect of platelet activating factor on guinea-pig myometrium, Prostaglandins, 32, 539, 10.1016/0090-6980(86)90036-5 Tetta, 1986, et al: platelet activating factor contracts human myometrium in vitro, Proc Soc Exp Biol Med, 183, 376, 10.3181/00379727-183-42435 Alloatti, 1986, Effect of platelet-activating factor (PAF) on human cardiac muscle, Int Arch Allergy Appl Immunol, 79, 108, 10.1159/000233953 Levi, 1984, Acetyl glyceryl ether phosphorylcholine (AGEPC), a putative mediator of cardiac anaphylaxis in the guinea pig, Circ Res, 54, 117, 10.1161/01.RES.54.2.117 Robertson, 1987, Negative inotropic effect on platelet-activating factor on human myocardium: a pharmacological study, J Pharmacol Exp Ther, 243, 834 Robertson, 1988, Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity, J Pharmacol Exp Ther, 245, 124 Finkelman, 2007, Anaphylaxis: lessons from mouse models, J Allergy Clin Immunol, 120, 506, 10.1016/j.jaci.2007.07.033 Vadas, 2008, Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis, N Engl J Med, 358, 28, 10.1056/NEJMoa070030 Terashita, 1987, A lethal role of platelet activating factor in anaphylactic shock in mice, J Pharmacol Exp Ther, 243, 378 Vargaftig, 1987, PAF-acether today − relevance for acute experimental anaphylaxis, Br Med Bull, 43, 312, 10.1093/oxfordjournals.bmb.a072185 Fukuda, 2000, Effect of human plasma-type platelet-activating factor acetylhydrolase in two anaphylactic shock models, Eur J Pharmacol, 390, 203, 10.1016/S0014-2999(99)00920-6 Vadas, 2013, Platelet-activating factor, histamine, and tryptase levels in human anaphylaxis, J Allergy Clin Immunol, 131, 144, 10.1016/j.jaci.2012.08.016 Li, 2009, Inter-individual variability of plasma PAF-acetylhydrolase activity in ARDS patients and PAFAH genotype, J Clin Pharm Ther, 34, 447, 10.1111/j.1365-2710.2008.01014.x Finkelman, 2010, Peanut allergy and anaphylaxis, Curr Opin Immunol, 22, 783, 10.1016/j.coi.2010.10.005 Khodoun, 2009, Peanuts can contribute to anaphylactic shock by activating complement, J Allergy Clin Immunol, 123, 342, 10.1016/j.jaci.2008.11.004 Church, 2010, The scope of pharmacological and clinical effects of modern antihistamines, with a special focus on rupatadine: proceedings from a satellite symposium held at the 21st world allergy congress, Buenos Aires, December 8, 2009, World Allergy Organ J, 3, S1 Nagi-Miura, 2007, Involvement of platelet activating factor, histamine and serotonin in acute lethal shock induced by Candida albicans water-soluble extracellular polysaccharide fraction (CAWS) in mice, Biol Pharm Bull, 30, 1354, 10.1248/bpb.30.1354 Alevizos, 2013, Rupatadine inhibits inflammatory mediator release from human laboratory of allergic diseases 2 cultured mast cells stimulated by platelet-activating factor, Allergy Asthma Immunol, 111, 542, 10.1016/j.anai.2013.08.025 Siebenhaar, 2013, et al Rupatadine improves quality of life in mastocytosis: a randomized, double-blind, placebo-controlled trial, Allergy, 68, 949, 10.1111/all.12159 Liebhart, 2014, Idiopatyczna anafilaksja: trudny problem diagnostyczny i terapeutyczny, Alergia, 1, 5 Akin, 2007, Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with idiopathic anaphylaxis, Blood, 110, 2331, 10.1182/blood-2006-06-028100 Hitomi, 2009, Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma, J Allergy Clin Immunol, 124, 779, 10.1016/j.jaci.2009.07.044 Górska, 2016, The role of TRAF4 and B3GAT1 gene expression in the food hypersensitivity and insect venom allergy in mastocytosis, Arch Immunol Ther Exp (Warsz), 64, 497, 10.1007/s00005-016-0397-7 Apter, 2008, Clinical and genetic risk factors of self-reported penicillin allergy, J Allergy Clin Immunol, 122, 152, 10.1016/j.jaci.2008.03.037 Guglielmi, 2006, IL-10 promoter and IL4-Ralpha gene SNPs are associated with immediate beta-lactam allergy in atopic women, Allergy, 61, 921, 10.1111/j.1398-9995.2006.01067.x